Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Will Thursday have an impact?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(73)
•••
Comment by Sailboatdreamon Apr 26, 2021 1:18pm
187 Views
Post# 33067462

RE:RE:RE:RE:RE:RE:RE:Will Thursday have an impact?

RE:RE:RE:RE:RE:RE:RE:Will Thursday have an impact?

BioTeck wrote: We have been in a drought since January. No more news till June would not be anything out of the ordinary. One would think Phil would like to release something juicy before the AGM but not sure there is anythign to release. You may want to consult with the glass half full types however. 

 

If there is no major news release / announcement between now and AGM that is a major problem. Although complex, major deals can be done quickly when parties are motivated.  Certainly within the months available to management since Jan breakthrough.  Whether the glass is half full or half empty, result is the same... we are missing half the glass.  Where is it?!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities